STAT

JANUARY 6, 2024

STAT now publishes selected Letters to the Editor received in response to First Opinion essays to encourage robust, good-faith discussion about difficult issues. Submit a Letter to the Editor  here , or find the submission form at the end of any First Opinion essay. “ There’s a public health crisis lurking in our data: the Census option ‘some other race ,’” by Juan Carlos Gonzalez Jr.

239

239

Safe Biologics

JANUARY 6, 2024

In November, the Centers for Medicare and Medicaid Services (CMS) announced a Proposed Rule that would permit Medicare Part D plan sponsors to substitute non-interchangeable biosimilars in place of the biologic medicines now used to treat many chronic conditions such as rheumatoid arthritis, Crohn’s disease and cancer. Read ASBM’s statement on the announcement here.

Biosimilars 100

Biosimilars 100

The Guardian - Pharmaceutical Industry

JANUARY 6, 2024

Many firms see the dire forecasts as ‘overblown’ but they know they will have to adapt products to make ‘every bite must count’ On a drizzly morning Luton’s takeaways are preparing for the lunchtime rush. McDonald’s is busy with shoppers, while chains from Subway to German Doner Kebab are opening their doors for the approaching army of hungry stomachs.

Hospitals 84

Hospitals Diabetes 84

BioPharma Dive

JANUARY 6, 2024

The Emeryville, California- based gene therapy developer has several preclinical programs in development with Moderna, Ionis and Affini-T.

81

81

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Drug Patent Watch

JANUARY 6, 2024

This chart shows the drugs with the most patents in Philippines. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.… The post Which pharmaceutical drugs have the most drug patents in Philippines? appeared first on DrugPatentWatch - Make Better Decisions.

59

59

Express Pharma

JANUARY 6, 2024

The Ministry of Health and Family Welfare (MoHFW) announced revised rules under Schedule M of the Drugs and Cosmetics Rules, 1945 , through a notification published in the Gazette of India. The Central government, along with the Drugs Technical Advisory Board (DTAB), notified the amended rules under the Drugs (Amendment) Rules, 2023. The revised Schedule M includes the introduction of a pharma quality system (PQS), quality risk management (QRM), product quality review (PQR), and specific guideli

100

100